Memory CD8+ T cells upregulate glycolysis and effector functions under limiting oxygen conditions
暂无分享,去创建一个
F. V. van Alphen | A. Verhoeven | K. V. van Gisbergen | M. van den Biggelaar | Natasja A M Kragten | Ammarina Beumer-Chuwonpad | Julian J. Freen-van Heeren | Maria Rodriguez Gomez
[1] A. Brazma,et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences , 2021, Nucleic Acids Res..
[2] D. Cantrell,et al. Quantitative Analyses Reveal How Hypoxia Reconfigures the Proteome of Primary Cytotoxic T Lymphocytes , 2021, Frontiers in Immunology.
[3] C. Yee,et al. Hypoxia acts as an environmental cue for the human tissue-resident memory T cell differentiation program , 2021, JCI insight.
[4] A. Goldrath,et al. Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells. , 2021, The Journal of clinical investigation.
[5] M. Kornberg. The immunologic Warburg effect: Evidence and therapeutic opportunities in autoimmunity , 2020, Wiley interdisciplinary reviews. Systems biology and medicine.
[6] J. Paul Robinson,et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) , 2019, European journal of immunology.
[7] David O’Sullivan. The metabolic spectrum of memory T cells , 2019, Immunology and cell biology.
[8] B. Nicolet,et al. Costimulation through TLR2 Drives Polyfunctional CD8+ T Cell Responses , 2018, The Journal of Immunology.
[9] V. Badovinac,et al. Defining Memory CD8 T Cell , 2018, Front. Immunol..
[10] B. Nelson,et al. Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study , 2018, Oncoimmunology.
[11] R. Stark,et al. Armed and Ready: Transcriptional Regulation of Tissue-Resident Memory CD8 T Cells , 2018, Front. Immunol..
[12] W. Morrison,et al. Granzyme B Is an Essential Mediator in CD8+ T Cell Killing of Theileria parva-Infected Cells , 2018, Infection and Immunity.
[13] T. Kuijpers,et al. Efficient production of erythroid, megakaryoid and myeloid cells, using single cell-derived iPSC colony differentiation , 2018, bioRxiv.
[14] E. Pearce,et al. Unraveling the Complex Interplay Between T Cell Metabolism and Function. , 2018, Annual review of immunology.
[15] S. Jameson,et al. Understanding Subset Diversity in T Cell Memory. , 2018, Immunity.
[16] H. Young,et al. Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions , 2018, Cell reports.
[17] I. Amelio,et al. The hypoxic tumour microenvironment , 2018, Oncogenesis.
[18] L. Galluzzi,et al. The spectrum of T cell metabolism in health and disease , 2017, Nature Reviews Immunology.
[19] Ziv Porat,et al. Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function. , 2017, Cell reports.
[20] F. Sánchez‐Madrid,et al. CD69: from activation marker to metabolic gatekeeper , 2017, European journal of immunology.
[21] Michael D. Buck,et al. Metabolic Instruction of Immunity , 2017, Cell.
[22] F. Sánchez‐Madrid,et al. CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes , 2017, Oncoimmunology.
[23] U. V. von Andrian,et al. The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis. , 2016, Immunity.
[24] J. Neilson,et al. Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. , 2016, The Journal of clinical investigation.
[25] O. Kretz,et al. Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming , 2016, Cell.
[26] Marco Y. Hein,et al. The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.
[27] G. V. D. van der Windt,et al. Measuring Bioenergetics in T Cells Using a Seahorse Extracellular Flux Analyzer , 2016, Current protocols in immunology.
[28] Chih-Hao Chang,et al. Emerging concepts of T cell metabolism as a target of immunotherapy , 2016, Nature Immunology.
[29] P. Walker,et al. Phenotypic switch of CD8+ T cells reactivated under hypoxia toward IL‐10 secreting, poorly proliferative effector cells , 2015, European journal of immunology.
[30] S. Rosenberg,et al. Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] B. Igyártó,et al. Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance , 2015, Cell.
[32] Quynh-Mai Pham,et al. Oral infection drives a distinct population of intestinal resident memory CD8(+) T cells with enhanced protective function. , 2014, Immunity.
[33] Ajit S. Divakaruni,et al. Analysis and interpretation of microplate-based oxygen consumption and pH data. , 2014, Methods in enzymology.
[34] E. Yang,et al. Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen , 2013, Nature Immunology.
[35] C. Hess,et al. Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch , 2013, Nature Immunology.
[36] B. Faubert,et al. CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability , 2013, Proceedings of the National Academy of Sciences.
[37] B. Faubert,et al. Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis , 2013, Cell.
[38] Thomas Gebhardt,et al. Memory T cell subsets, migration patterns, and tissue residence. , 2013, Annual review of immunology.
[39] J. Licht,et al. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. , 2013, Immunity.
[40] Jeffrey E. Lee,et al. Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients , 2012, Clinical Cancer Research.
[41] V. Sondak,et al. Efficacy of Adoptive Cell Transfer of Tumor-infiltrating Lymphocytes After Lymphopenia Induction for Metastatic Melanoma , 2012, Journal of immunotherapy.
[42] G. V. D. Windt,et al. Metabolic switching and fuel choice during T‐cell differentiation and memory development , 2012, Immunological reviews.
[43] G. V. D. van der Windt,et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. , 2012, Immunity.
[44] David K. Finlay,et al. University of Dundee PDK 1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD 8 T cells , 2012 .
[45] Matko Bosnjak,et al. REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms , 2011, PloS one.
[46] S. Steinberg,et al. Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy , 2011, Clinical Cancer Research.
[47] W. Burns,et al. Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy. , 2011, Blood.
[48] J. Rathmell,et al. The metabolic life and times of a T‐cell , 2010, Immunological reviews.
[49] Hao Shen,et al. Quick to remember, slow to forget: rapid recall responses of memory CD8+ T cells , 2010, Cell Research.
[50] Thomas Gebhardt,et al. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus , 2009, Nature Immunology.
[51] Israel Steinfeld,et al. BMC Bioinformatics BioMed Central , 2008 .
[52] M. Roederer,et al. T-cell quality in memory and protection: implications for vaccine design , 2008, Nature Reviews Immunology.
[53] E. Wherry,et al. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. , 2007, Immunity.
[54] S. Rosenberg,et al. Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. , 2005, The Journal of clinical investigation.
[55] L. Herzenberg,et al. Culturing at atmospheric oxygen levels impacts lymphocyte function. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[56] J. Harty,et al. CD8+ T cell contraction is controlled by early inflammation , 2004, Nature Immunology.
[57] C. Thompson,et al. The CD28 signaling pathway regulates glucose metabolism. , 2002, Immunity.
[58] Susan M. Kaech,et al. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. , 2002 .
[59] M. Sitkovsky,et al. Differential Effects of Physiologically Relevant Hypoxic Conditions on T Lymphocyte Development and Effector Functions , 2001, The Journal of Immunology.
[60] Dirk Homann,et al. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory , 2001, Nature Medicine.
[61] Stephen P. Schoenberger,et al. Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation , 2001, Nature Immunology.
[62] L. Lefrançois,et al. Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue , 2001, Science.
[63] Henrique Veiga-Fernandes,et al. Response of naïve and memory CD8+ T cells to antigen stimulation in vivo , 2000, Nature Immunology.
[64] F. Sallusto,et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.
[65] H. Eisen,et al. Functional differences between memory and naive CD8 T cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[66] M. Bevan,et al. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. , 1998, Immunity.